Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial

OBJECTIVE: To determine whether droxidopa, an oral norepinephrine precursor, improves symptomatic neurogenic orthostatic hypotension (nOH). METHODS: Patients with symptomatic nOH due to Parkinson disease, multiple system atrophy, pure autonomic failure, or nondiabetic autonomic neuropathy underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Horacio, Freeman, Roy, Biaggioni, Italo, Low, Phillip, Pedder, Simon, Hewitt, L. Arthur, Mauney, Joe, Feirtag, Michael, Mathias, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115605/
https://www.ncbi.nlm.nih.gov/pubmed/24944260
http://dx.doi.org/10.1212/WNL.0000000000000615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115605/
https://www.ncbi.nlm.nih.gov/pubmed/24944260
http://dx.doi.org/10.1212/WNL.0000000000000615

Ejemplares similares